Peter Karayiannis

Prof. Peter Karayiannis

orcid

Research Focus & Metrics

Academic Career Length

47Years (1980-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 January 1996 in Science
Verified
Journal Article
Closed access
PDF file
JLJeff Linnen
Jeff Linnen
JWJohn Wages
John Wages
ZZZhen-Yong Zhang-Keck
Zhen-Yong Zhang-Keck
KFKirk E. Fry
Kirk E. Fry
KKKrzysztof Z. Krawczynski
Krzysztof Z. Krawczynski
JKJungsuh P. Kim
Jungsuh P. Kim
An RNA virus, designated hepatitis G virus (HGV), was identified from the plasma of a patient with chronic hepatitis. Extension from an immunoreactive complementary DNA clone yielded the entire genome (9392 nucleotides) encoding a polyprotein of 2873 amino acids. The virus is closely related to GB virus C (GBV-C) and distantly related to hepatitis C virus, GBV-A, and GBV-B. HGV was associated with acute and chronic hepatitis. Persistent viremia was detected for up to 9 years in patients with hepatitis. The virus is transfusion-transmissible. It has a global distribution and is present within the volunteer blood donor population in the United States.

1 September 1989 in The Lancet
Verified
Journal Article
Closed access
WCW.F Carman
W.F Carman
SHS Hadziyannis
S Hadziyannis
MMM.J Mcgarvey
M.J Mcgarvey
MJM.R Jacyna
M.R Jacyna
PKPeter Karayiannis
Peter Karayiannis
HTH.C Thomas
H.C Thomas

1 August 1990 in The Lancet
Verified
Journal Article
Closed access
WCW F Carman
W F Carman
AZA R Zanetti
A R Zanetti
PKPeter Karayiannis
Peter Karayiannis
JWJ Waters
J Waters
GMG Manzillo
G Manzillo
HTH C Thomas
H C Thomas

1 May 1985 in Hepatology
Verified
Journal Article
Closed access
PDF file
CCChia-Ming Chu
Chia-Ming Chu
PKPeter Karayiannis
Peter Karayiannis
MFMartin J. F. Fowler
Martin J. F. Fowler
JMJon Monjardino
Jon Monjardino
YLYun-Fan Liaw
Yun-Fan Liaw
HTHoward C. Thomas
Howard C. Thomas

1 November 1989 in Hepatology
Verified
Journal Article
Closed access
PDF file
GBGary M. Brook
Gary M. Brook
PKPeter Karayiannis
Peter Karayiannis
HTHoward C. Thomas
Howard C. Thomas

15 May 2004 in Journal of Virology
Verified
Journal Article
Closed access
PDF file
DFDaniel M. Forton
Daniel M. Forton
PKPeter Karayiannis
Peter Karayiannis
NMNadiya Mahmud
Nadiya Mahmud
STSimon D. Taylor-Robinson
Simon D. Taylor-Robinson
HTHoward C. Thomas
Howard C. Thomas
Reports of cerebral dysfunction in chronic hepatitis C virus (HCV) infection have led to the suggestion that HCV may infect the central nervous system (CNS). We used reverse transcription-PCR, cloning, and sequencing to define quasispecies for the HCV internal ribosomal entry site (IRES) and hypervariable region 1 (HVR1) in autopsy-derived brain, liver, lymph node, and serum samples. There was evidence of tissue compartmentalization of sequences in the brain in two patients, with between 24 and 55% of brain-derived IRES sequences absent from the serum, and significant phylogenetic and phenetic clustering of the brain and lymph node HVR1 sequences. The IRES initiates cap-independent translation of the viral polyprotein. Two unique brain-derived IRES mutations (C 204 →A and G 243 →A), which have previously been associated with lymphoid replication and altered translational efficiency in cell culture, were found in one patient. We used a dicistronic reporter vector to test whether brain-derived variants showed altered IRES-mediated translational efficiency, which might favor CNS infection. The translational efficiencies of the brain-derived IRES sequences were generally reduced compared to those of the master serum and liver sequences in rabbit reticulocyte cell lysates and two human cell lines, HuH7 (liver) and CHME3 (microglial). The C 204 →A and G 243 →A mutations showed preserved translational efficiency in HuH7 cells but reduced efficiency in CHME3 cells. Our data provide evidence that the CNS is a site of HCV replication, consistent with the recent demonstration of negative-strand HCV RNA in brain, and suggest that IRES polymorphisms may be important as a viral strategy of reduced translation to favor latency in the CNS.